{
    "organizations": [],
    "uuid": "e2a00db11ff2d71bb24fede11629779d85c2ee5a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medivir-successful-completion-of-p/brief-medivir-successful-completion-of-pre-clinical-safety-studies-with-miv-818-idUSFWN1P302G",
    "ord_in_thread": 0,
    "title": "BRIEF-Medivir: successful completion of pre-clinical safety studies with MIV-818",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Medivir:\n* SUCCESSFUL COMPLETION OF PRE-CLINICAL SAFETY STUDIES WITH MIV-818, ENABLING START OF PHASE I CLINICAL STUDIES IN 2018 Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)\n ",
    "published": "2018-01-08T15:38:00.000+02:00",
    "crawled": "2018-01-09T17:10:21.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "medivir",
        "successful",
        "completion",
        "safety",
        "study",
        "enabling",
        "start",
        "phase",
        "clinical",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "stockholm",
        "newsroom"
    ]
}